现代医院2015，Vol.15Issue(5)：31-33,3.DOI:10.3969/j.issn.1671-332X.2015.05.011
泛耐药鲍曼不动杆菌肺部感染疗效分析
THE CLINICAL EFFICACY OF PNEUMONIA CAUSED BY PAN DRUG-RESISTANT ACINE-TOBACTER BAUMAN
摘要
Abstract
Objective To retrospectively analyze the clinical efficacy of different anti-inflammatory treat-ment of pneumonia caused by Pan drugresistant Acinetobacter Bauman ( PDRAB) , in order to provide reference for the clinical treatment.Methods Cases of positive PDRAB detected from lower respiratory tract specimens in our hospital from June 2012 to July 2014 were selected to make a retrospective summary of treatment and prognosis.Results The single drug group had 103 cases, with the total effective rate of 28.15%.The combined treatment group had 83 cases, with the total effective rate of 32.53%.There was no significant difference in efficacy of anti-inflam-matory treatment of PDRAB pneumonia between the two groups.Conclusion Clinically, PDRAB pneumonia is treated with empirical antimicrobial drugs.Cefoperazone sodium sulbactam sodium or cefoperazone he azole temple combined with levofloxacin are expected to improve the clinical efficacy of PDRAB pneumonia.关键词
泛耐药性/鲍曼不动杆菌/肺部感染Key words
Pan drugresistant/Acinetobacter Bauman/Pneumonia引用本文复制引用
林冠文,刘瑛,刘蕴婷,林茂锐,方晓琳..泛耐药鲍曼不动杆菌肺部感染疗效分析[J].现代医院,2015,15(5):31-33,3.基金项目
广东省医学科研基金(编号:A2014154) （编号:A2014154）
